Ravind Rahul, Kumar Priyadarshini Venkatram, Prabaharan Sasikala
Department of Radiation Oncology, HCG Bangalore Institute of Oncology, Bangalore, Karnataka, India.
BMJ Case Rep. 2016 Apr 8;2016:bcr2016214700. doi: 10.1136/bcr-2016-214700.
Inflammatory breast cancer (IBC) is a relatively rare and aggressive subtype, accounting for nearly 2.5% of all diagnosed breast cancers worldwide. It is usually characterised by an acute onset, rapid clinical progression, poor prognosis and micrometastasis at the time of presentation. Prompt recognition of clinical symptoms and identification of warning signs are vital in diagnosing and appropriately treating a patient with IBC.
炎性乳腺癌（IBC）是一种相对罕见且侵袭性较强的亚型，占全球所有确诊乳腺癌的近2.5%。其通常的特点是起病急、临床进展迅速、预后差且在就诊时已发生微转移。及时识别临床症状和发现警示信号对于诊断和恰当治疗IBC患者至关重要。
